Titre : Hypertension rénovasculaire

Hypertension rénovasculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Safety-net Providers
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypertension rénovasculaire : Questions médicales les plus fréquentes", "headline": "Hypertension rénovasculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypertension rénovasculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-30", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypertension rénovasculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypertension rénale", "url": "https://questionsmedicales.fr/mesh/D006977", "about": { "@type": "MedicalCondition", "name": "Hypertension rénale", "code": { "@type": "MedicalCode", "code": "D006977", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.489.631" } } }, "about": { "@type": "MedicalCondition", "name": "Hypertension rénovasculaire", "alternateName": "Hypertension, Renovascular", "code": { "@type": "MedicalCode", "code": "D006978", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Eduardo Colombari", "url": "https://questionsmedicales.fr/author/Eduardo%20Colombari", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Kjell Tullus", "url": "https://questionsmedicales.fr/author/Kjell%20Tullus", "affiliation": { "@type": "Organization", "name": "Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust." } }, { "@type": "Person", "name": "Mariana Rosso Melo", "url": "https://questionsmedicales.fr/author/Mariana%20Rosso%20Melo", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Jose V Menani", "url": "https://questionsmedicales.fr/author/Jose%20V%20Menani", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Mariana R Lauar", "url": "https://questionsmedicales.fr/author/Mariana%20R%20Lauar", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pathology, School of Dentistry, São Paulo State University, UNESP, Araraquara, SP, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital.", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37236319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.oret.2023.05.014" } }, { "@type": "ScholarlyArticle", "name": "A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety-net hospital.", "datePublished": "2024-02-18", "url": "https://questionsmedicales.fr/article/38369695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jvh.13913" } }, { "@type": "ScholarlyArticle", "name": "Before and During Pandemic Telemedicine Use: An Analysis of Rural and Urban Safety-Net Clinics.", "datePublished": "2022-09-10", "url": "https://questionsmedicales.fr/article/36096960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amepre.2022.06.012" } }, { "@type": "ScholarlyArticle", "name": "Spanish-Speaking Status: A Protective Factor in Colorectal Cancer Presentation at a Safety-Net Hospital.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36041340", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jss.2022.06.060" } }, { "@type": "ScholarlyArticle", "name": "At the intersection of trust and mistrust: A qualitative analysis of motivators and barriers to research participation at a safety-net hospital.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36896842", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/hex.13726" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Hypertension artérielle", "item": "https://questionsmedicales.fr/mesh/D006973" }, { "@type": "ListItem", "position": 5, "name": "Hypertension rénale", "item": "https://questionsmedicales.fr/mesh/D006977" }, { "@type": "ListItem", "position": 6, "name": "Hypertension rénovasculaire", "item": "https://questionsmedicales.fr/mesh/D006978" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypertension rénovasculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypertension rénovasculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypertension rénovasculaire", "description": "Comment diagnostiquer l'hypertension rénovasculaire ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent une hypertension rénovasculaire ?\nQuel rôle joue l'angiographie dans le diagnostic ?\nPeut-on utiliser des tests sanguins pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypertension rénovasculaire", "description": "Quels sont les symptômes de l'hypertension rénovasculaire ?\nL'hypertension rénovasculaire cause-t-elle des douleurs ?\nComment l'hypertension rénovasculaire affecte-t-elle la santé ?\nY a-t-il des symptômes spécifiques chez les jeunes ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypertension rénovasculaire", "description": "Comment prévenir l'hypertension rénovasculaire ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir cette condition ?\nFumer influence-t-il l'hypertension rénovasculaire ?\nLe stress a-t-il un impact sur l'hypertension ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypertension rénovasculaire", "description": "Quels traitements sont disponibles pour l'hypertension rénovasculaire ?\nQuand la chirurgie est-elle nécessaire ?\nQuels médicaments sont couramment prescrits ?\nComment surveiller l'efficacité du traitement ?\nY a-t-il des effets secondaires aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypertension rénovasculaire", "description": "Quelles sont les complications de l'hypertension rénovasculaire ?\nComment l'hypertension rénovasculaire affecte-t-elle les reins ?\nY a-t-il un risque accru d'AVC ?\nQuels sont les effets sur le cœur ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypertension rénovasculaire", "description": "Quels sont les principaux facteurs de risque ?\nLe diabète influence-t-il l'hypertension rénovasculaire ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Safety-net+Providers&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypertension rénovasculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique, l'imagerie et des tests de fonction rénale." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie Doppler, l'IRM et l'angiographie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une hypertension rénovasculaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une hypertension résistante aux traitements et des anomalies rénales peuvent indiquer cette condition." } }, { "@type": "Question", "name": "Quel rôle joue l'angiographie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'angiographie permet de visualiser les artères rénales et d'identifier les rétrécissements." } }, { "@type": "Question", "name": "Peut-on utiliser des tests sanguins pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent évaluer la fonction rénale et détecter des anomalies." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hypertension rénovasculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles de la vision." } }, { "@type": "Question", "name": "L'hypertension rénovasculaire cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des douleurs abdominales ou lombaires en raison de l'ischémie rénale." } }, { "@type": "Question", "name": "Comment l'hypertension rénovasculaire affecte-t-elle la santé ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des complications cardiovasculaires et rénales graves si non traitée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les jeunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes peuvent présenter une hypertension sévère sans antécédents familiaux." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus aigus chez les jeunes et plus insidieux chez les âgés." } }, { "@type": "Question", "name": "Comment prévenir l'hypertension rénovasculaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, contrôler le poids et surveiller la pression artérielle." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, pauvre en sel et riche en potassium, aide à prévenir l'hypertension." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir cette condition ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier contribue à maintenir une pression artérielle normale." } }, { "@type": "Question", "name": "Fumer influence-t-il l'hypertension rénovasculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme aggrave les problèmes vasculaires et augmente le risque d'hypertension." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'hypertension ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'élévation de la pression artérielle." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'hypertension rénovasculaire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments antihypertenseurs et des interventions chirurgicales." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée en cas de rétrécissement sévère ou de résistance au traitement médical." } }, { "@type": "Question", "name": "Quels médicaments sont couramment prescrits ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs de l'ECA, les bloqueurs des récepteurs de l'angiotensine et les diurétiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La pression artérielle et la fonction rénale doivent être régulièrement surveillées." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires peuvent inclure des hypotensions, des vertiges et des troubles électrolytiques." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hypertension rénovasculaire ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, les AVC et les maladies cardiaques." } }, { "@type": "Question", "name": "Comment l'hypertension rénovasculaire affecte-t-elle les reins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une ischémie rénale, entraînant une insuffisance rénale chronique." } }, { "@type": "Question", "name": "Y a-t-il un risque accru d'AVC ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension rénovasculaire augmente le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Quels sont les effets sur le cœur ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une hypertrophie cardiaque et des maladies coronariennes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et précoce." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'hypertension antérieure, le tabagisme et le diabète." } }, { "@type": "Question", "name": "Le diabète influence-t-il l'hypertension rénovasculaire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque de maladies vasculaires et d'hypertension rénovasculaire." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'hypertension augmentent le risque de développer cette condition." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire contribue à l'obésité et à l'hypertension." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'élévation de la pression artérielle." } } ] } ] }

Sources (10000 au total)

Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital.

To identify individual and systems-focused risk factors for pars plana vitrectomy among patients with proliferative diabetic retinopathy (PDR) in a diverse, urban, safety-net hospital setting.... Single-center, retrospective, observational, case-control study at Zuckerberg San Francisco General Hospital and Trauma Center between 2017 and 2022.... Two hundred twenty-two patients with PDR over a 5-year span (2017-2022), consisting of 111 cases who underwent vitrectomy for vision-threatening complications (tractional retinal detachment, noncleari... Medical records were reviewed from time of entry into hospital system to vitrectomy date (or date-matched clinic visit for controls). Individual-focused exposures included age, gender, ethnicity, lang... Odds ratios (ORs) for each exposure on vision-threatening diabetic complications requiring vitrectomy.... The absence of panretinal photocoagulation was the primary significant individual-focused risk factor for vitrectomy in the multivariable analysis (OR, 4.78; P = 0.011). Systems-focused risk factors i... Largely modifiable variables modulate risk of complications requiring diabetic vitrectomy. Each additional month of loss-to-follow-up for patients with active proliferative disease increased odds of v... Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article....

Before and During Pandemic Telemedicine Use: An Analysis of Rural and Urban Safety-Net Clinics.

Differences in face-to-face and telemedicine visits before and during the COVID-19 pandemic among rural and urban safety-net clinic patients were evaluated. In addition, this study investigated whethe... Using electronic health record data from safety-net clinics, patients aged ≥18 years with ≥1 visit before or during the COVID-19 pandemic, March 1, 2019-March 31, 2021, were identified, and trends in ... Included patients (N=1,015,722) were seen in 446 safety-net clinics: 83% urban, 10.3% large rural, 4.1% small rural, and 2.6% isolated rural. Before COVID-19, little difference in the percentage of en... Despite the increased use of telemedicine in response to the pandemic, rural patients had significantly fewer telemedicine visits than those in more urban areas. Equitable access to telemedicine will ...

Spanish-Speaking Status: A Protective Factor in Colorectal Cancer Presentation at a Safety-Net Hospital.

Lower screening rates and poorer outcomes for colorectal cancer have been associated with Hispanic ethnicity and Spanish-speaking status, respectively.... We reviewed sequential colorectal cancer patients evaluated by the surgical service at a safety-net hospital (SNH) (2016-2019). Insurance type, stage, cancer type, surgery class (elective/urgent), ini... Of 157 patients, 85 (54.1%) were men, 91 (58.0%) had colon cancer, 67 (42.7%) primarily spoke Spanish, and late stage (III or IV) presentations occurred in 83 (52.9%) patients. The median age was 58 y... Spanish-speaking status was associated with a lower likelihood of emergent presentation and need for palliative surgery among SNH colorectal cancer patients. Further research is needed to determine if...

At the intersection of trust and mistrust: A qualitative analysis of motivators and barriers to research participation at a safety-net hospital.

The underrepresentation of Black, Indigenous, and People of Color (BIPOC) individuals in healthcare research limits generalizability and contributes to healthcare inequities. Existing barriers and att... We conducted semi-structured qualitative interviews with patients at an urban safety net hospital, focusing on facilitators, barriers, motivators, and preferences for research participation. We conduc... We completed 38 interviews and identified six major themes related to preferences for engagement in research participation: (1) wide variation in research recruitment preferences; (2) logistical compl... Despite barriers to participation in research studies among safety-net populations, there are also facilitators that can be implemented to increase knowledge and comprehension, ease of participation, ... Our analysis methods and study progress were presented to individuals within the Boston Medical Center healthcare system. Through this process community engagement specialists, clinical experts, resea...

Surviving the COVID-19 pandemic: navigating the recovery of breast imaging services in a safety-net hospital.

The purpose of this study was to determine the impact of COVID-19 on county safety-net breast imaging services and describe the steps taken to actively manage and mitigate delays.... This was an IRB exempt retrospective review of our county safety-net breast imaging practice analyzed for 4 distinct time periods: (1) "Shut-down period": March 17, 2020 to May 17, 2020; (2) "Phased r... Our safety-net practice sustained significant volume losses during the first 3 time periods with a 99% reduction in screening mammography in the shut-down period. Cancers diagnosed decreased by 17% in... Through specific community outreach programs and optimized navigation, our safety-net breast imaging practice was able to mitigate the impact of COVID-19 on our patient population by increasing patien...

Frequency and nature of discussing social influences on health in urban safety-net clinics: A qualitative analysis.

Chronic social isolation is a risk factor for all-cause mortality and disease progression, but is not routinely screened for in clinical settings. This study analyzed provider-patient communication pa... Content analysis was conducted on transcripts of 97 audiotaped, English-speaking patient encounters with 27 primary care providers at 3 safety-net primary care centers in New York City. Conversations ... Transcripts included no explicit examples of social isolation screening. Social influences on health were discussed meaningfully in only 28 % of transcripts, compared to medication adherence (93 %) an... Social influences on health, including social isolation, were uncommonly discussed in this sample of primary care visits. When social influences were discussed meaningfully, providers utilized relatio... Strategic conversations about social influences, even when brief and informal, can effectively screen patients for social isolation....